8-K
Current Report
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-20-003774
Results of operations
- Item 2.02 Results of operations and financial condition
From the SEC's structured data for this filing
Loading a2019q4-earningsrelease.htm…